Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hsin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
JTCVS Techniques|October 14, 2021
Commentary: How best to quantify an uplifting pectus operation?Aliss Chang, Michael Hsin
The Journal of Thoracic and Cardiovascular Surgery|October 20, 2018
Retransplantation improves survival in pediatric lung transplant recipientsMichael Hsin, Marcelo Cypel
Seminars in Thoracic and Cardiovascular Surgery|June 23, 2020
Commentary: Do Robots Do it Better?Jianxin Shi, Michael Hsin
Journal of Thoracic Disease|July 21, 2018
Ex vivo lung perfusion: a potential platform for molecular diagnosis and <i>ex vivo</i> organ repairMichael Hsin, Tim Au
The Journal of Thoracic and Cardiovascular Surgery|February 2, 2020
Commentary: Chronic thromboembolic pulmonary hypertension and the misguided thrombusMichael Hsin, Katherine Fan
The Journal of Thoracic and Cardiovascular Surgery|January 9, 2021
Commentary: Gift of life in the time of COVID-19Michael Hsin, Marcelo Cypel
The Journal of Thoracic and Cardiovascular Surgery|June 5, 2021
Commentary: Is size everything in the management of ground-glass opacities?Ka-Lun Mak, Michael Hsin
JTCVS Open|August 25, 2022
Commentary: Postrecurrence survival in patients with lung cancer after curative surgery warrants systematic investigation to optimize management strategiesChi Sum Yuen, Michael Hsin
JTCVS Open|August 25, 2022
Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertensionMichael K L Wong, Michael Hsin
Thoracic Cancer|September 19, 2017
Management of malignant pleural effusion: Options and recommended approachesLinda Leung, Michael Hsin, Kwok Chi Lam
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
JTCVS Techniques|October 14, 2021
Commentary: How best to quantify an uplifting pectus operation?Aliss Chang, Michael Hsin
The Journal of Thoracic and Cardiovascular Surgery|October 20, 2018
Retransplantation improves survival in pediatric lung transplant recipientsMichael Hsin, Marcelo Cypel
Seminars in Thoracic and Cardiovascular Surgery|June 23, 2020
Commentary: Do Robots Do it Better?Jianxin Shi, Michael Hsin
Journal of Thoracic Disease|July 21, 2018
Ex vivo lung perfusion: a potential platform for molecular diagnosis and <i>ex vivo</i> organ repairMichael Hsin, Tim Au
The Journal of Thoracic and Cardiovascular Surgery|February 2, 2020
Commentary: Chronic thromboembolic pulmonary hypertension and the misguided thrombusMichael Hsin, Katherine Fan
The Journal of Thoracic and Cardiovascular Surgery|January 9, 2021
Commentary: Gift of life in the time of COVID-19Michael Hsin, Marcelo Cypel
The Journal of Thoracic and Cardiovascular Surgery|June 5, 2021
Commentary: Is size everything in the management of ground-glass opacities?Ka-Lun Mak, Michael Hsin
JTCVS Open|August 25, 2022
Commentary: Postrecurrence survival in patients with lung cancer after curative surgery warrants systematic investigation to optimize management strategiesChi Sum Yuen, Michael Hsin
JTCVS Open|August 25, 2022
Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertensionMichael K L Wong, Michael Hsin
Thoracic Cancer|September 19, 2017
Management of malignant pleural effusion: Options and recommended approachesLinda Leung, Michael Hsin, Kwok Chi Lam
Pageof 4